Member Info for Cloudy390

Absolutely agree , big sells ,big buys, should make no difference,the value is in the science and the confirmed products not in some bod Who wants to buy 50 100 thousand shares or sell shares they have not got, or sell shares because they want a few quid profit.Its not on ,the value is in the products , so wake up and smell the coffee

John but why why why, doesn’t make sense.

This is madness, the patents, the progression of tls501,the progression of foralumab in MS,Crohn’s and Alzheimer’s is worth more than £160mill plus ATM ,at least 5 times as much ,as tils 501 is 7 times more potent and more safe than Actemera alone. Maddness!

Maybe they will submit proposals at a discussion in the AGM and not vote on it just let it be mulled over for a while and then voted on at a GM as alluded to by the RNS.
The Company will also put proposals to shareholders at the Annual General Meeting to obtain the approval necessary for a capital reduction which will be required to implement the demerger."
I agree it’s not very clear at the mo.

No worries, I think people ought to focus on Kunwar after all he is the who invented all this and Dr Wiener who is going to trial for Alzheimer’s with there nasal formula. Mr Cerrone is doing a brilliant job of financing it all and I heard someone say he is crap because he was a director of the HIV drug sold to BMS for 5mill .I say they bought that in pre clinical so that’s why thy want proof in humans and after if they bought a dud hiv drug who’s fault is that as I’m sure they scrutinised it scientifically. Sour grapes, but this is not that. Nuf said.

I don’t think Mr Cerrone would be happy with Big Pharma taking a large stake in tils as I’ve known CEO’s where that’s happened and all they do is interfere.

Maybe he was stalling or did not know what he was doing!

StemprintER as said by Mr Cerrone could be up and running early next, so I don’t think there would be to much to do or cost.

I should check before posting!

Yes sorry it was sobi
https://www.fiercebiotech.com/biotech/sobi-to-buy-novimmune-r-d-assets-lay-off-90-staff

Yes I can find it again

I read somewhere not to long ago that Sanofi bought the R&D arm of Novimmune the company which developed tls 501 and foralumab.

A bit of goood news will turbo charge this, Covid update,or trials starting, or even StemprintER, which I must admit I totally disregarded in the early days,or even all three!

Could it be ATM sells, I don’t know how that works?

Ditto here. He does seem to know what he is doing, and has from the start.

Someone is hoovering up shares!

Well I thought Mr Cerrone was very positive about what is going to happen,so I for one will be very interested to see what transpires .

I also heard him say that StemprintER in a new company would be able to raise its own funding,so if not sold they can continue with StemprintER as I’m sure he also said that they have a company ready to manufacturer. I may have dreamt that ,but I’m pretty sure I did not.

Strange, as I distinctly heard Mr Cerrone in one interview that StemprintER could be commercialised and marketed early next year. Anyone else hear that?

I assume they will reduce the nominal share value.